We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
501
MacroGenics
MGNX
$235M
$1.43M 0.02%
+75,000
New +$1.4M
GGP
502
DELISTED
GGP Inc.
GGP
$1.42M 0.02%
60,760
-5,375
-8% -$120K
ODP
503
DELISTED
ODP
ODP
$1.42M 0.02%
40,051
-21,821
-35% -$756K
TRI icon
504
Thomson Reuters
TRI
$39.4B
$1.41M 0.02%
27,776
-154,792
-85% -$8.09M
RNAC icon
505
Cartesian Therapeutics
RNAC
$232M
$1.4M 0.02%
4,767
– –
KSS icon
506
Kohl's
KSS
$2.03B
$1.4M 0.02%
25,841
+9,394
+57% +$432K
SCTL
507
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.39M 0.02%
167,250
– –
KTWO
508
DELISTED
K2M Group Holdings, Inc
KTWO
$1.39M 0.02%
77,000
+32,000
+71% +$608K
VTR icon
509
Ventas
VTR
$48.9B
$1.38M 0.02%
23,061
– –
TEVA icon
510
Teva Pharmaceuticals
TEVA
$35.9B
$1.36M 0.02%
71,908
+20,000
+39% +$301K
URI icon
511
United Rentals
URI
$71.1B
$1.36M 0.02%
7,925
+713
+10% +$109K
EFX icon
512
Equifax
EFX
$20.3B
$1.34M 0.02%
11,395
-302
-3% -$33.9K
ESS icon
513
Essex Property Trust
ESS
$18.9B
$1.33M 0.02%
5,502
+228
+4% +$57.5K
VNO icon
514
Vornado Realty Trust
VNO
$7.47B
$1.33M 0.02%
16,977
-437
-3% -$33.4K
CAH icon
515
Cardinal Health
CAH
$53.4B
$1.33M 0.02%
21,633
-1,904
-8% -$118K
OMED
516
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.31M 0.02%
320,000
-50,000
-14% -$218K
HST icon
517
Host Hotels & Resorts
HST
$16.8B
$1.31M 0.02%
65,842
-122,919
-65% -$2.41M
RARX
518
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.28M 0.02%
151,000
+35,000
+30% +$430K
EGRX
519
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.28M 0.02%
24,000
-35,000
-59% -$1.95M
BTI icon
520
British American Tobacco
BTI
$132B
$1.28M 0.02%
19,103
-1,047
-5% -$68.3K
RHI icon
521
Robert Half
RHI
$3.61B
$1.27M 0.02%
22,940
-4,710
-17% -$251K
TDG icon
522
TransDigm Group
TDG
$69.2B
$1.27M 0.02%
4,635
+877
+23% +$238K
B
523
Barrick Mining
B
$62.2B
$1.27M 0.02%
87,282
+66,622
+322% +$982K
CPRI icon
524
Capri Holdings
CPRI
$1.77B
$1.26M 0.02%
20,102
-196,593
-91% -$10.8M
TXRH icon
525
Texas Roadhouse
TXRH
$12.7B
$1.26M 0.02%
+24,000
New +$1.21M
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.